Insiders Trades
Fermentalg Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest was filed 25 Jun 2024.
Fermentalg: what insiders have been doing
Every trade that managers of Fermentalg disclose to AMF is tracked on this page. The company sits in the Food & Agriculture sector. Between 18 October 2025 and 18 October 2026, 1 insider published 1 filing.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 316 companies tracked on its exchange, the median is 6 filings; at 1 filing, this issuer sits below that mark. Since 2021, the database holds 3 purchases and 60 sales by insiders of the company.
No insider has bought Fermentalg shares on the open market in the past twelve months.
In the same sector, recent insider purchases at Village Farms International, Inc. and Orkla ASA also feature in our signals. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Insider Decl.
80
Thresholds
n/a
Buy Volume
€113,177
3 ops. · all time
Sell Volume
€3M
60 ops. · all time
Analyst consensus: bullish or bearish?
Analysts rate Fermentalg Strong Buy (bullish), based on 2 analysts. Average price target: €0.59.
Fundamental score
Ranked 23,572 of 24,148 companies
11.1
score / 100
Value11
Quality11
FCF yld-16%
Earn yld-19%
EV/EBITDA·
ROE-30%
Gross mgn17%
Net mgn-71%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€0.41
Analyst consensus
2 analystsStrong buy
€0.52Target €0.59(+42%)€0.65
Income statement
Revenue€13.4M
Gross profit€2.3M17% margin
EBITDA-€5.9M-44% margin
Net income-€9.4M-71.1% margin
Valuation
PER (forward)-8.3x
P/Book1.6x
Beta1.06
Balance sheet & cash
Market cap€49.5M
Total debt€5.0M
Free Cash Flow-€8.1M
Debt / Equity12%
Profitability & ownership
ROE-29.9%
ROA-15.2%
% insiders15.6%
% institutions17.9%
Last declaration on 26 November 2025
Declarations80 total
3,410 shares0ActionEuronext Growth ParisISIN FR00112718002025DD1071151
21,000 shares@ €0.4037100.0% of flowActionEuronext Growth ParisISIN FR00112716002024DD982796
Canonical exit: 17 Sept 2024 (T+90)
100,000 shares@ €0.422100.0% of flowActionEuronext Growth ParisISIN FR00112716002024DD982180
Canonical exit: 16 Sept 2024 (T+90)
2,500,000 shares@ €0.4024.0% of flowActionHors plateforme de négociationISIN FR00112716002024DD982319
5,000,000 shares@ €0.4039.1% of flowActionHors plateforme de négociationISIN FR00112716002024DD982321
9,500 shares0ActionHors plateforme de négociationISIN FR00112716002023DD933152
25,000 shares0ActionHors plateforme de négociationISIN FR00112716002023DD933162
9,500 shares0ActionHors plateforme de négociationISIN FR00112716002023DD933163
35,714 shares@ €1.75100.0% of flowBSA (Bons de souscription en actions)Hors plateforme de négociationISIN FR00112716002022DD842961
Canonical exit: 16 Aug 2022 (T+90)
4,326 shares@ €3.05290.3% of flowActionEuronext ParisISIN FR00112716002022DD819013
4,326 shares@ €3.05290.3% of flowActionEuronext ParisISIN FR00112716002022DD819014
7,056 shares@ €3.10010.5% of flowActionEuronext ParisISIN FR00112716002022DD814450
14,740 shares@ €3.10010.9% of flowActionEuronext ParisISIN FR00112716002022DD814451
12,026 shares@ €3.16440.9% of flowActionEuronext ParisISIN FR00112716002022DD814614
8,314 shares@ €3.1330.5% of flowActionEuronext ParisISIN FR00112716002022DD814615
8,314 shares@ €3.1330.6% of flowActionEuronext ParisISIN FR00112716002022DD814621
3,954 shares@ €3.1460.2% of flowActionEuronext ParisISIN FR00112716002022DD814626
8,735 shares@ €3.10930.5% of flowActionEuronext ParisISIN FR00112716002022DD815448
8,735 shares@ €3.10930.7% of flowActionEuronext ParisISIN FR00112716002022DD815449
261 shares@ €3.050.0% of flowActionEuronext ParisISIN FR00112716002021DD813935
125 shares@ €3.050.0% of flowActionEuronext ParisISIN FR00112716002021DD813937
1,000,000 shares0Actions résultant de la conversion des OCAHors plateforme de négociationISIN FR00112716002021DD812295
1,000,000 shares0Actions résultant de la conversion des OCHors plateforme de négociationISIN FR00112716002021DD812296
104,720 shares@ €1.753.6% of flowActions résultant de l'exercice de BSA-OCHors plateforme de négociationISIN FR00135195502021DD811933
17,070 shares@ €3.13691.0% of flowActionEuronext ParisISIN FR00112716002021DD811932
25 of 80 declarations
About Fermentalg
Fermentalg is a French industrial biotechnology company focused on the design, production and commercialization of solutions derived from microalgae. Founded in 2009 in Libourne, in the Gironde region of France, the company was built on the idea that microalgae can serve as a powerful technology platform to address major challenges in health, nutrition and sustainability. Listed on Euronext Growth Paris, Fermentalg has evolved from a pioneering start-up into a recognized industrial player in microalgae biotechnology, with capabilities spanning research, development, industrial scale-up and commercialization.
Fermentalg’s core business is centered on natural BioSolutions for human nutrition, animal nutrition and functional ingredients. Its portfolio includes algal omega-3 ingredients under the ΩRIGINS™ brand, aimed at vegan and vegetarian consumers as well as food and nutrition manufacturers seeking a traceable, sustainable alternative to marine-sourced oils. The company also develops natural microalgae-based ingredients for colorants, antioxidants and other functional applications, while maintaining broader innovation efforts in areas such as photosynthesis-based carbon capture.
Read moreShow less
From a historical perspective, Fermentalg has passed several important milestones. In 2010, it identified a unique microalgae strain, followed by the industrialization of omega-3 oils between 2014 and 2019. In 2017, the company sharpened its strategy around three core programs: functional lipids, natural proteins and carbon capture through photosynthesis. It has also formed strategic partnerships with major industrial groups, including Givaudan for a natural blue colorant, Suez through the CarbonWorks joint venture, and HuvePharma for industrial-scale omega-3 production. More recently, in April 2026, Fermentalg launched a new EPA/DHA omega-3 generation, underscoring its ongoing innovation drive and ambition to strengthen its nutritional ingredients platform.
Geographically, the company remains anchored in Libourne, southwestern France, while serving an international ecosystem of partners and customers. Its model combines scientific expertise, intellectual property, industrial partnerships and commercialization capabilities. Notable features of the company also include ESG-related certifications and a governance framework presented as aligned with the standards expected from listed mid-cap companies. Overall, Fermentalg positions itself as a European specialist in microalgae, operating at the intersection of food ingredients, health nutrition and sustainable biotechnology.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
